Tara Marie Watson

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 177 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada

Carol Strıke, Tara Marie Watson · International Journal of Drug Policy · 2019 · 116 citations

Nursing, Health Policy, Substance Use Disorders +14

Risk creating and risk reducing: Community perceptions of supervised consumption facilities for illicit drug use

Gillian Kolla, Carol Strıke, Tara Marie Watson et al. · Health Risk & Society · 2017 · 83 citations

Public Health, Community Health, Health Promotion +11

Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale

Nazlee Maghsoudi, Karen McDonald, Cristiana Stefan et al. · Harm Reduction Journal · 2020 · 64 citations · Full text

Pharmacy, Toxicology, Analytical Toxicology +16

Critical studies of harm reduction: Overdose response in uncertain political times

Tara Marie Watson, Gillian Kolla, Emily van der Meulen et al. · International Journal of Drug Policy · 2019 · 59 citations

Nursing, Political Science, Public Policy +7